Since the pharmacological effect of DOX is manifested through the induction of oxidative stress [10], we speculate that the observed GJA1 overexpression in DOX-resistant tumor cells may be an attempt by cells to reduce reactive oxygen species production in response to xenobiotic stress. The gene discussed is GJA1; the disease is neoplasm.